Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Predicine logo — Advancing precision medicine through next-generation liquid...

Predicine

Advancing precision medicine through next-generation liquid biopsy oncology platform

Founded 2015 United States Hayward, United States 89 employees Biotechnology, Health Care +1

General Information

Company Name Predicine
Founded Year 2015
Location United States Hayward, United States
Founders / Decision Makers
Team member Team member
Employees 89
Industries Biotechnology, Health Care, Life Sciences
Social

BounceWatch is an independent company data service, not affiliated with Predicine. To contact Predicine, visit predicine.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Predicine compare?

A PDF of Predicine and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Predicine soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Predicine

Predicine is a global molecular insights company that focuses on advancing precision medicine in oncology. The company has developed a breakthrough cell-free DNA- and cell-free RNA-based liquid biopsy technology, enabling minimally invasive molecular diagnosis for treatment selection, therapy monitoring, and minimal residual disease and early cancer detection. Predicine has launched a portfolio of blood-, urine- and tissue-based diagnostic assays for oncology. With business operations in Silicon Valley, Houston, Shanghai, Singapore, and Boston, Predicine collaborates with leading biopharma companies, institutions, and governments to support personalized healthcare globally. Since its establishment in 2015, the company operates within the Biotechnology, Health Care, and Life Sciences industries. While specific details about the last investment and investors are not available, Predicine's innovative approach and international presence position it as an intriguing player in the advancement of precision medicine.

Business keywords: Precision Medicine, Liquid Biopsy, Oncology Diagnostics, Biomarker Development, Genomic Profiling, Clinical Trials Support, Molecular Diagnostics, Therapy Monitoring, Minimal Residual Disease Detection, Early Cancer Detection, Genomic Data Analytics, Biopharma Partnerships, Infectious Disease Diagnostics, MRD (Minimal Residual Disease) Monitoring, COVID-19 Diagnostics

No funding data available for Predicine yet.

Latest News

View All
Freenome Appoints Linh H. Le as Chief Financial Officer — Biospace.com
Freenome Appoints Linh H. Le as Chief Financial Officer
Biospace.com Nov 23, 2025

Predicine Alternatives & Competitors

View All Alternatives
Predicine vs
Exai Bio
Exai Bio United States

Delivering next-generation liquid biopsy platform for the earliest detection and most accurate cance...

22 employees
Biotechnology, Health Care
Predicine vs
Rarity Bioscience
Rarity Bioscience Sweden

Ultra-sensitive and multiplex nucleic acid assays for fast and cost efficient mutation detection in...

Seed
18 employees
Biotechnology, Health Care
Predicine vs
Personalis, Inc.
Personalis, Inc. United States

Ultrasensitive ctDNA testing

IPO
401 employees
Biotechnology, Health Care
View all alternatives

FAQ About Predicine

Advancing precision medicine through next-generation liquid biopsy oncology platform
Predicine was founded in 2015.
Predicine is headquartered in Hayward, United States.
Predicine operates in Biotechnology, Health Care and Life Sciences. Its work centres on Precision Medicine, Liquid Biopsy, Oncology Diagnostics and Biomarker Development.
Predicine has approximately 89 employees.
Top alternatives and competitors to Predicine include Exai Bio, Rarity Bioscience , Personalis, Inc., Foresight Diagnostics (a Natera company), Adaptive Biotechnologies Corp.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Predicine and Exai Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Predicine, https://bouncewatch.com/company/predicine, updated 26 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes